Pierre Fabre Laboratories

Pierre Fabre Laboratories is a global company renowned for its unparalleled combination of pharmaceutical and dermocosmetics expertise. The group holds a significant position in the industry, being the second largest dermo-cosmetics laboratory and the second largest private French pharmaceutical group. With a diverse portfolio including well-established medical franchises and international brands, Pierre Fabre Laboratories continues to lead the market in various segments. The company's commitment to innovation is evident through its multiple innovation and research centers, reflecting its dedication to product development. Generating substantial revenues of €2.7 billion in 2022, with a notable 69% from international operations, the company has showcased its global impact and reach. Additionally, the unique company structure with majority ownership by the Pierre Fabre Foundation and employee stock ownership plan demonstrates a strategic approach to governance. Notably, in 2020, ECOCERT Environment recognized Pierre Fabre's commitment to corporate social responsibility at an "excellence" level, marking a significant achievement. Overall, Pierre Fabre Laboratories stands as a prominent player in the biotechnology, health, and wellness, and pharmaceutical sectors, poised for continued growth and success.